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The use of electronic health records
(EHRs) as a source of “big data” in car-
diovascular research is attracting
interest and investments. Integrating
EHRs from multiple sources can poten-
tially provide huge data sets for analysis.
Another potentially very effective
approach is to focus more on data
quality instead of quantity. We evalu-
ated the applicability of large-scale data
integration from multiple electronic
sources to produce extensive and high
quality cardiovascular (CVD) pheno-
type data for survival analysis and the
possible benefit of using novel machine
learning [1]. For this purpose, we inte-
grated clinical data recorded by treating
physicians with other EHR data of all
consecutive acute coronary syndrome
(ACS) patients diagnosed invasively by
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We set out to find out if models developed with a hospital’s own data beat a current state-of-the art risk
predictor for mortality in acute coronary syndrome. Our data of 9,066 patients was collected and integrated
from operational clinical electronic health records. Our best classifier, XGBoost, achieved a performance of
AUC 0.890 and beat the current generic gold standard, GRACE (AUC 0.822).
coronary angiography over a 10-year
period (2007 -2017).
To achieve this, we generated high
quality phenotype data for a retrospec-
tive analysis of 9,066 consecutive
patients (95% of all patients) under-
going coronary angiography for their
first episode of ACS in a single tertiary
care centre. Our main outcome was six-
month mortality. Using regression
analysis and machine learning method
extreme gradient boosting (XGBoost)
[2], multivariable risk prediction
models were developed in a separate
training set (patients treated in 2007-
2014 and 2017, n=7151) and validated
and compared to the Global Registry of
Acute Coronary Events (GRACE) [3]
score in a validation set (patients treated
in 2015-2016, n=1771) with the full
GRACE score data available.
In the entire study population, overall
six-month mortality was 7.3 % (n=660).
Many of the same variables were asso-
ciated highly significantly with six-
month mortality in both the regression
and XGBoost analyses, indicating good
data quality in the training set.
Observing the performance of these
methods in the validation set revealed
that xgboost had the best predictive per-
formance (AUC 0.890) when compared
to logistic regression model (AUC
0.871, p=0.012 for difference in AUCs)
and compared to the GRACE score
(AUC 0.822, p<0.00001 for difference
in AUCs) (Figure 1). 
These results show that clinical data as
recorded by physicians during treat-
ment and conventional EHR data can be
combined to produce extensive CVD
phenotype data that works effectively in
the prediction of mortality after ACS.
The use of a machine learning algo-
rithm such as gradient boosting leads to
a more accurate prediction of mortality
when compared to conventional regres-
sion analysis. The use of CVD pheno-
type data, either by conventional
logistic regression or by machine
learning, leads to significantly more
accurate results when compared to the
highly validated GRACE score specifi-
cally designed for the prediction of six-
month mortality after admission for
ACS. In conclusion, the use of both
high quality phenotypic data and novel
machine learning significantly
improves prediction of mortality in
ACS over the traditional GRACE score. 
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Figure1:Comparisonofmodelperformanceby
receivingoperatingcharacteristiccurvesfordifferent
riskpredictionmodelsforsixmonthmortalityamong
patientsundergoingcoronaryangiographyinTays
HeartHospitalforacutecoronarysyndromeduring
years2015and2016(n=1722withn=122fatalities
duringasix-monthfollow-up).
